دورية أكاديمية
أعرض في EDS

An opinion on the debatable function of brain resident immune protein, T-cell receptor beta subunit in the central nervous system.

التفاصيل البيبلوغرافية
العنوان: An opinion on the debatable function of brain resident immune protein, T-cell receptor beta subunit in the central nervous system.
المؤلفون: Komal P; Department of Biological Sciences, Birla Institute of Technology and Sciences (BITS)-Pilani (Hyderabad Campus), Shameerpet, Mandal, Hyderabad, Telangana 500078, India., Manjari SKV; Department of Biological Sciences, Birla Institute of Technology and Sciences (BITS)-Pilani (Hyderabad Campus), Shameerpet, Mandal, Hyderabad, Telangana 500078, India., Nashmi R; Department of Biology, Division of Medical Sciences, University of Victoria, PO Box 3020, Station CSC, Victoria, BC, V8W 3N5, Canada.
المصدر: IBRO neuroscience reports [IBRO Neurosci Rep] 2022 Sep 06; Vol. 13, pp. 235-242. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101775148 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-2421 (Electronic) Linking ISSN: 26672421 NLM ISO Abbreviation: IBRO Neurosci Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam] : Elsevier B.V., [2021]-
مستخلص: In recent years scientific research has established that the nervous and immune systems have shared molecular signaling components. Proteins native to immune cells, which are also found in the brain, have neuronal functions in the nervous system where they affect synaptic plasticity, axonal regeneration, neurogenesis, and neurotransmission. Certain native immune molecules like major histocompatibility complex I (MHC-I), paired immunoglobulin receptor B (PirB), toll-like receptor (TLR), cluster of differentiation-3 zeta (CD3ζ), CD4 co-receptor, and T-cell receptor beta (TCR-β) expression in neurons have been extensively documented. In this review, we provide our opinion and discussed the possible roles of T-cell receptor beta subunits in modulating the function of neurons in the central nervous system. Based on the previous findings of Syken and Shatz., 2003; Nishiyori et al., 2004; Rodriguez et., 1993 and Komal et., 2014; we discuss whether restrictive expression of TCR-β subunits in selected brain regions could be involved in the pathology of neurological disorders and whether their aberrant enhancement in expression may be considered as a suitable biomarker for aging or neurodegenerative diseases like Huntington's disease (HD).
Competing Interests: The authors declare no conflict of interest.
(© 2022 The Authors.)
References: J Neurosci. 2014 Apr 30;34(18):6146-55. (PMID: 24790185)
Front Cell Dev Biol. 2020 Oct 16;8:597627. (PMID: 33178706)
Neurol Res. 2017 Jan;39(1):73-82. (PMID: 27809706)
Physiol Rev. 2011 Apr;91(2):461-553. (PMID: 21527731)
Front Immunol. 2019 Sep 12;10:2171. (PMID: 31572381)
Front Neurosci. 2021 Sep 20;15:665820. (PMID: 34616271)
Ann Neurol. 2002 Mar;51(3):311-8. (PMID: 11891826)
Int Immunol. 1994 Mar;6(3):377-85. (PMID: 8186189)
J Clin Invest. 1985 Sep;76(3):1283-5. (PMID: 2995449)
Mol Immunol. 2018 Oct;102:3-13. (PMID: 29958698)
Behav Brain Res. 2011 Aug 10;221(2):555-63. (PMID: 21145918)
Intravital. 2012;1(2):95-106. (PMID: 24078900)
Nature. 1988 Aug 4;334(6181):395-402. (PMID: 3043226)
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20771-6. (PMID: 24302763)
Nat Rev Neurosci. 2004 Jul;5(7):521-31. (PMID: 15208694)
Biomed Res Int. 2014;2014:791238. (PMID: 25197660)
Biochem Pharmacol. 2015 Oct 15;97(4):512-517. (PMID: 26212542)
Prog Neurobiol. 2021 Nov;206:102154. (PMID: 34453977)
Exp Mol Med. 2021 Feb;53(2):281-290. (PMID: 33594256)
Neurobiol Dis. 2014 Mar;63:129-40. (PMID: 24326163)
Front Mol Neurosci. 2019 Mar 19;12:68. (PMID: 30941013)
Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a002485. (PMID: 20516133)
Infect Immun. 2002 Jul;70(7):3701-6. (PMID: 12065512)
Dev Cell. 2015 Feb 23;32(4):491-501. (PMID: 25710535)
Front Cell Neurosci. 2018 Dec 18;12:488. (PMID: 30618635)
Am J Psychiatry. 2013 Aug;170(8):877-85. (PMID: 23903335)
Auto Immun Highlights. 2020 Jan 22;11(1):2. (PMID: 32127039)
Sci Immunol. 2020 Sep 4;5(51):. (PMID: 32887843)
Mol Biol Cell. 2008 Jun;19(6):2444-56. (PMID: 18367546)
Front Cell Dev Biol. 2021 Jul 12;9:703338. (PMID: 34322489)
J Huntingtons Dis. 2016 Dec 15;5(4):333-342. (PMID: 27983560)
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18172-18174. (PMID: 32690689)
Semin Pediatr Neurol. 2017 Aug;24(3):145-151. (PMID: 29103421)
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22278-83. (PMID: 21135233)
Front Neurosci. 2020 Feb 18;14:45. (PMID: 32132891)
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13048-53. (PMID: 14569018)
Neural Regen Res. 2021 Dec;16(12):2521-2527. (PMID: 33907043)
J Biol Chem. 2021 Jan-Jun;296:100402. (PMID: 33571523)
J Alzheimers Dis. 2021;79(1):127-139. (PMID: 33216025)
Cell. 1991 Jan 11;64(1):189-200. (PMID: 1986864)
Neuron. 2009 Oct 15;64(1):40-5. (PMID: 19840547)
Front Pharmacol. 2019 Sep 12;10:1008. (PMID: 31572186)
Genome Med. 2022 Jan 7;14(1):2. (PMID: 34991709)
Nat Neurosci. 2019 Mar;22(3):374-385. (PMID: 30718903)
Neurobiol Dis. 2020 Mar;136:104741. (PMID: 31931142)
J Exp Med. 2010 Jul 5;207(7):1555-67. (PMID: 20566715)
J Neurosci. 2014 Jan 1;34(1):22-35. (PMID: 24381265)
Rev Neurol. 2007 Mar 1-15;44(5):298-302. (PMID: 17342681)
EMBO J. 2012 Apr 18;31(8):1853-64. (PMID: 22446390)
Neuron. 1998 Sep;21(3):505-20. (PMID: 9768838)
J Clin Invest. 2009 Jan;119(1):182-92. (PMID: 19104149)
Front Neurosci. 2020 Feb 06;14:82. (PMID: 32116525)
Trends Immunol. 2003 Oct;24(10):554-60. (PMID: 14552840)
Nature. 2014 May 8;509(7499):195-200. (PMID: 24695230)
Science. 2000 Dec 15;290(5499):2155-9. (PMID: 11118151)
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9831-5. (PMID: 3200860)
Cell Rep. 2021 Jul 13;36(2):109390. (PMID: 34260911)
J Physiol. 2015 Aug 15;593(16):3513-32. (PMID: 25990637)
Nat Rev Drug Discov. 2013 Nov;12(11):827. (PMID: 24172329)
Genesis. 2001 Apr;29(4):156-62. (PMID: 11309848)
Int J Mol Sci. 2021 Apr 28;22(9):. (PMID: 33925147)
J Neurosci. 2007 Aug 1;27(31):8202-18. (PMID: 17670967)
Neuroscience. 2022 Jun 1;492:67-81. (PMID: 35413386)
Aging Dis. 2018 Jun 1;9(3):412-425. (PMID: 29896429)
J Neuroimmunol. 1993 Aug;47(1):95-100. (PMID: 8376551)
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):49. (PMID: 30263032)
Cell. 1989 Jun 30;57(7):1095-100. (PMID: 2567636)
J Neuroinflammation. 2020 Mar 27;17(1):95. (PMID: 32220257)
Eur J Neurosci. 2008 Jun;27(11):2803-20. (PMID: 18588526)
Mov Disord. 2021 Aug;36(8):1805-1814. (PMID: 33973677)
Front Neurol. 2018 Mar 19;9:159. (PMID: 29615958)
J Neuroinflammation. 2020 Nov 3;17(1):328. (PMID: 33143727)
Exp Neurobiol. 2019 Oct 31;28(5):547-553. (PMID: 31698547)
Nat Genet. 2020 Nov;52(11):1158-1168. (PMID: 33106633)
J Mol Neurosci. 2006;30(1-2):181-4. (PMID: 17192671)
J Neuroinflammation. 2012 Jul 02;9:155. (PMID: 22747919)
Front Cell Neurosci. 2021 Jun 15;15:689332. (PMID: 34211373)
J Neuroinflammation. 2020 Nov 25;17(1):354. (PMID: 33239010)
Science. 2013 Sep 20;341(6152):1399-404. (PMID: 24052308)
Nat Rev Immunol. 2008 Nov;8(11):895-900. (PMID: 18846098)
Mol Neurodegener. 2018 Aug 9;13(1):43. (PMID: 30092810)
J Neurosci. 2012 Jun 6;32(23):8004-11. (PMID: 22674275)
Int J Mol Sci. 2022 Jan 11;23(2):. (PMID: 35054963)
Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):. (PMID: 35074870)
Acta Neuropathol Commun. 2020 Jul 1;8(1):96. (PMID: 32611392)
J Comp Neurol. 2004 Feb 2;469(2):214-26. (PMID: 14694535)
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16096-16099. (PMID: 32581125)
Mol Neurobiol. 2021 Nov;58(11):5986-6005. (PMID: 34432266)
Nat Commun. 2019 Oct 1;10(1):4451. (PMID: 31575864)
Front Neuroanat. 2014 Oct 13;8:114. (PMID: 25352786)
NPJ Genom Med. 2021 Sep 28;6(1):80. (PMID: 34584092)
Neuron Glia Biol. 2004 Aug;1(3):283-9. (PMID: 18185853)
Nat Neurosci. 2012 Jul 26;15(8):1096-101. (PMID: 22837040)
Science. 1992 Dec 18;258(5090):1903-10. (PMID: 1361685)
Front Cell Neurosci. 2020 Jul 29;14:209. (PMID: 32848613)
فهرسة مساهمة: Keywords: AD, Alzheimer's disease; CP-AMPA, calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; Central nervous system (CNS); HD, Huntington's disease; Immune receptors; LTP, long-term potentiation; Major histocompatibility complex I (MHC-I); NMDA, N-methyl-D-aspartate; Neurodegeneration; PD, Parkinson's disease; T-cell receptors (TCRs); TAP-1, transporter associated with antigen processing 1; α7 nAChRs, alpha7 nicotinic acetylcholine receptors
تواريخ الأحداث: Date Created: 20230102 Latest Revision: 20230103
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9795316
DOI: 10.1016/j.ibneur.2022.09.003
PMID: 36590097
قاعدة البيانات: MEDLINE
الوصف
تدمد:2667-2421
DOI:10.1016/j.ibneur.2022.09.003